Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ashim Aggarwal is active.

Publication


Featured researches published by Ashim Aggarwal.


The Annals of Thoracic Surgery | 2012

Incidence and Management of Gastrointestinal Bleeding With Continuous Flow Assist Devices

Ashim Aggarwal; Rojina Pant; Shivani Kumar; Priya Sharma; Colleen Gallagher; Antone Tatooles; Pat Pappas; Geetha Bhat

BACKGROUND Continuous flow left ventricular assist devices (CF-LVADs) have emerged as the standard of care for patients in advanced heart failure (HF) requiring long-term mechanical circulatory support. Gastrointestinal (GI) bleeding has been frequently reported within this population. METHODS A retrospective analysis of 101 patients implanted with the Heart Mate II from January 2005 to August 2011 was performed to identify incidence, etiology, and management of GI bleeding. Univariate and multivariate regression analysis was conducted to identify related risk factors. RESULTS A significant incidence of GI bleeding (22.8%) occurred in our predominantly destination therapy (DT) (93%) population. Fifty-seven percent of the patients with bleeding episodes bled from the upper GI (UGI) tract (with 54% bleeding from gastric erosions and 37% from ulcers/angiodysplasias), whereas 35% of patients bled from the lower GI (LGI) tract. Previous history of GI bleeding (odds ratio [OR], 22.7; 95% CI, 2.2-228.6; p=0.008), elevated international normalized ratio (INR) (OR, 3.9; CI, 1.2-12.9; p=0.02), and low platelet count (OR, -0.98; CI, 0.98 -0.99; p=0.001) were independent predictors of GI hemorrhage. Recurrent bleeding was more common in older patients (mean, 70 years; p=0.01). The majority of bleeders (60%) rebled from the same site. Management strategies included temporarily withholding anticoagulation, decreasing the speed of LVADs, and using octreotide. Octreotide did not impact the amount of packed red blood cells used, rebleeding rates, length of hospital stay, or all-cause mortality. Only 1 patient died as a direct consequence of GI bleeding. CONCLUSIONS Multiple factors account for GI bleeding in patients on CF-VADs. A previous history of bleeding increases risk significantly and warrants careful monitoring.


The Annals of Thoracic Surgery | 2013

The Development of Aortic Insufficiency in Continuous-Flow Left Ventricular Assist Device–Supported Patients

Ashim Aggarwal; Rashmi Raghuvir; Paula Eryazici; Gregory Macaluso; Priya Sharma; Christopher Blair; Antone Tatooles; Pat Pappas; Geetha Bhat

BACKGROUND Significant aortic insufficiency (AI) after left ventricular assist device (LVAD) placement affects device performance and end-organ perfusion. This study examined the development and progression of AI after implantation of continuous-flow LVAD. METHODS Seventy-nine patients undergoing Heart Mate II (Thoratec Corp, Pleasanton, CA) LVAD implantation for predominantly destination therapy (n = 69 [87%]) were examined. Preoperative and postoperative echocardiograms for all patients were reviewed at the intervals of 0 to 3, 3 to 6, 6 to 12, 12 to 18, and 18 to 24 months. AI was graded on an interval scale of 0, none; 0.5, trivial; 1, mild; 1.5, mild to moderate; 2, moderate; 2.5, moderate to severe; and 3, severe. Development and progression of AI were analyzed. RESULTS The incidence of significant AI (mild or greater) was 52% (n = 41). Median time to AI development was 187 days. The median duration of VAD support was 761 days. Mild AI developed in 41 patients (52%). No severe AI developed. In the Cox regression model (hazard ratio [95% confidence interval]), aortic valve closure (2.51 [1.06 to 5.89]; p = 0.03), and age (1.04 [1.008 to 1.08]; p = 0.01) were independent predictors of AI development. There was no difference in mortality rates in the two groups (p = 0.40 by log-rank test). A mixed-model linear regression analysis showed a significant overall progression of AI over time (β ± standard error, 0.06 ± 0.02; p = 0.006). CONCLUSIONS AI develops over time in a significant number of Heart Mate II LVAD patients. AI is more common in patients with closed aortic valves and in the older age group. As more patients require long-term VAD support, the development of AI will need careful attention and monitoring.


Asaio Journal | 2012

Are Blood Stream Infections Associated With an Increased Risk of Hemorrhagic Stroke in Patients With a Left Ventricular Assist Device

Ashim Aggarwal; Ankit Gupta; Shivani Kumar; Jane A. Baumblatt; Sunil Pauwaa; Colleen Gallagher; Adam Treitman; Pat Pappas; Antone Tatooles; Geetha Bhat

Blood stream infections (BSIs) are an important cause of morbidity and mortality in patients with left ventricular assist devices (LVADs). The aim of this study was to examine the correlation between hemorrhagic cerebrovascular accident (CVA) and BSI after implantation of LVAD for advanced heart failure (HF). This was a retrospective descriptive review of 87 patients with end-stage HF, who underwent implantation of HeartMate II continuous-flow LVAD over a 4 year period. Blood stream infections were diagnosed by serial blood cultures, and suspected neurological complications including CVAs were confirmed by neuroimaging. Extensive patient chart review was performed, and descriptive characteristics were analyzed using SPSS statistical software. The mean age of our study population was 62.3 ± 12.8 years, and the majority of our patients were males (n = 75, 86.2%). The baseline characteristics were comparable in the patients with and without CVAs. Patients with BSI had a much greater incidence of CVA compared to patients without BSI (n = 13, 43.3% vs. n = 5, 10.0%; p < 0.0001). There was an increased mortality in patients with BSI than those without (n = 57, 65.5% vs. n = 30, 34.5%; p = 0.003). The risk of all CVAs (hemorrhagic/ischemic) was eightfold (odds ratio [OR] = 7.9; 95% confidence interval [CI] = 2.4–25.5; p = 0.001] in patients with BSI. Patients with BSI had a >20-fold risk of hemorrhagic CVA (OR = 24; 95% CI = 2.8–201.1; p = 0.03). Advanced HF patients with LVAD support who developed BSI need urgent evaluation and close monitoring for suspected neurological complications, particularly hemorrhagic CVA.


Nutrition in Clinical Practice | 2013

Nutrition assessment in advanced heart failure patients evaluated for ventricular assist devices or cardiac transplantation.

Ashim Aggarwal; Anup Kumar; Mary Gregory; Christopher Blair; Sunil Pauwaa; Antone Tatooles; Pat Pappas; Geetha Bhat

BACKGROUND Malnutrition has been shown to affect clinical outcomes in patients with heart failure. The aim of this study was to analyze the incidence of malnutrition and to assess its prognostic significance in patients with advanced heart failure (AHF) (being evaluated for left ventricular assist device [LVAD] or cardiac transplant) based on nutrition status as assessed by the Mini Nutritional Assessment (MNA). METHODS A retrospective analysis was conducted on 154 patients. During evaluation, a complete nutrition assessment was performed, and diagnosis of malnutrition and risk of malnutrition was done with the MNA. Its possible independent association with mortality was assessed. RESULTS The mean (SD) age of the patients was 59.3 (14.1) years, with 76% men. Twenty-two percent were classified as malnourished, 68% at risk of malnutrition, and 10% well nourished. The mortality in the 3 groups was 26.5%, 42.0%, and 6.7%, respectively (P = .02). In the multivariate logistic regression analysis, the undernutrition state (malnourished + at risk) was an independent predictor of mortality (odds ratio, 7.9; confidence interval, 1.01-62.30; P = .04). CONCLUSIONS The state of undernutrition is an independent predictor of mortality in patients with AHF. Early recognition of undernutrition through use of the MNA may affect the long-term prognosis of these patients by enabling early intervention.


Cardiology Journal | 2012

How effective are continuous flow left ventricular assist devices in lowering high pulmonary artery pressures in heart transplant candidates

Sunil Pauwaa; Geetha Bhat; Antone Tatooles; Ashim Aggarwal; Michele Martin; Anup Kumar; Harshit Modi; Pat Pappas

BACKGROUND Pulmonary hypertension (PH) is considered a risk factor for morbidity and mortality in patients undergoing heart transplantation. Medical therapy with oral and pharmacologic agents is not always effective in reducing pulmonary artery (PA) pressures. Left ventricular assist devices (LVADs) have been used to reduce PA pressures in cases of PH unresponsive to medical therapy. METHODS AND RESULTS Our study sought to evaluate the effectiveness of axial- and centrifugal- continuous flow LVADs in reversing PH in heart transplant candidates. Hemodynamics were assessed pre- and post-operatively in nine patients undergoing HeartMate II and six patients undergoing HeartWare continuous flow LVADs. Mean PA pressures were reduced from 31.9 ± 10.6 mm Hg to 22.1 ± 6.6 mm Hg (p = 0.001), and pulmonary vascular resistance was reduced from 3.08 ± 1.6 mm Hg to 1.8 ± 1.0 mm Hg (p = 0.007). This improvement was seen within seven days of LVAD implantation. Three of 15 patients were successfully transplanted, with 100% survival at an average of 199 days post-transplant. CONCLUSIONS The results of this study suggest that both axial- and centrifugal-continuous flow LVADs are effective in immediately lowering PA pressures in heart transplant candidates with PH.


Asaio Journal | 2012

Experience with noncardiac surgery in destination therapy left ventricular assist devices patients.

Geetha Bhat; Shivani Kumar; Ashim Aggarwal; Sunil Pauwaa; German Rossell; Sudha Kurien; Anup Kumar; Pat Pappas; Antone Tatooles

Continuous flow left ventricular assist devices (CF-LVAD) are increasing the life expectancy of patients with advanced heart failure, with these patients undergoing more noncardiac operations after implantation. The purpose of this study was to determine the safety of noncardiac operations in destination therapy CF-LVAD patients. In a retrospective study of 110 CF-LVAD patients, we reviewed 36 patients who underwent 63 noncardiac operations 315.1 ± 333.5 days after LVAD placement. Fifty-four (84%) operations were elective and 10 were emergent. The mean age of the cohort was 61.4 ± 11.4 years, with the majority (81%) being men. Most patients (n = 24, 38%) underwent total abdominal operation. Of the 36 patients in the study, 23 (63.8%) patients required one surgical procedure, and 13(36.1%) patients underwent more than one procedure. Six critically ill patients (16%) of 37 expired within 30 days after emergent operation. Our study demonstrates overall good clinical outcomes with minimal intraoperative complications in LVAD patients undergoing noncardiac surgeries, except an increased propensity for intra- and postoperative transfusion of blood products because of complex coagulopathies.


Asaio Journal | 2012

Racial differences in patients with left ventricular assist devices.

Ashim Aggarwal; Ankit Gupta; Pat Pappas; Antone Tatooles; Geetha Bhat

We examined clinical outcomes based on ethnicity in patients undergoing left ventricular assist device (LVAD) implantation. We hypothesized that treatment in a specialized, comprehensive heart failure program results in similar survival between African Americans and whites. We retrospectively reviewed patient data implanted with HeartMate II (HM-II) LVAD over 2 years. There were 79 patients: 34 (43%) whites, 33 (42%) African Americans, and 12 (15%) patients belonging to other ethnicities there was no difference in demographics. The etiology of cardiomyopathy was more commonly ischemic in white patients compared to nonischemic in African American patients (p = 0.01). The mean left ventricular ejection fraction was 22.21 ± 10.66% in African American patients and 15.21 ± 5.54% in white patients (p = 0.008). The left ventricular end-diastolic (p = 0.06) and end-systolic (p = 0.03) diameters were greater in white patients compared to African American patients. Hypertension was seen in 79% of African American patients compared to 56% in white patients (p = 0.07). Survival by Kaplan–Meier analysis revealed an unadjusted survival advantage in African American patients (p = 0.04 by log-rank test), but this survival advantage was lost in multivariable Cox regression analysis after adjustment for other covariates. There was no difference in readmissions (p = 0.36). In patients with advanced heart failure undergoing HM-II LVAD implantation, African American patients had a similar survival and no difference in readmissions when compared with white patients despite significant differences in baseline clinical characteristics.


Progress in Transplantation | 2013

Evaluation and management of emergencies in patients with mechanical circulatory support devices

Ashim Aggarwal; Sudha Kurien; Laura Coyle; Roxanne Siemeck; Antone Tatooles; Pat Pappas; Geetha Bhat

Mechanical circulatory support devices such as ventricular assist devices have become the approved and accepted treatment option to improve survival and quality of life in patients with advanced heart failure refractory to medical therapy. Patients as a result are living longer and presenting to emergency medical services, primary care facilities, emergency departments, and critical care units more frequently. Currently, health care providers have limited experience in managing this complex patient population. Thus, we created a standardized method of initial evaluation and algorithmic approach of management to help in the management of emergencies in this unique patient population. We present a comprehensive overview of the types of mechanical assist devices, their complications, and an algorithmic approach to the emergency management in the patients with mechanical circulatory support. A systematic method is crucial in prompt and early recognition of emergencies to ensure appropriate management of these patients.


Heart & Lung | 2012

Recurrent Pseudomonas aortic root abscess complicating mitral valve endocarditis

Ashim Aggarwal; Nathan Ritter; Lohith Reddy; Deerajnath Lingutla; Farhad Nasar; Nayef El-Daher

We report on a man with Pseudomonas aeruginosa endocarditis causing an aortic root abscess. He underwent surgery with a homograft aortic root replacement and insertion of a tissue aortic valve. The patient then manifested recurrent aortic root infection and respiratory arrest, and eventually succumbed to sepsis. This case highlights the aggressive nature of an uncommon pathogen causing an atypical but lethal form of endocarditis, despite modern medical and surgical treatment.


Texas Heart Institute Journal | 2016

Ascending Aortic Pseudoaneurysm: Sleeping Giant Arises in 3rd Decade after Surgery

Ashim Aggarwal; Sandeep Banga; Sudhir Mungee

Twenty-eight years earlier, a 68-year-old woman had undergone chordal shortening to correct rheumatic anterior mitral leaflet prolapse and severe mitral regurgitation. At a much more recent presentation, a routine transthoracic echocardiogram incidentally revealed a 5.8-cm echolucent mass arising from the ascending aorta (Fig. 1). The patient was scheduled for urgent follow-up computed tomography (CT) of the chest, which she refused. A month later, she presented at the hospital with severe, sharp precordial chest pain. An emergency chest CT scan showed a giant (14 × 11-cm) ascending aortic pseudoaneurysm arising from the anterior aortic wall just distal to the sinotubular junction—at the aortic cannulation site of the previous cardiac surgery (Figs. 2 and ​and33). Fig. 1 Transthoracic echocardiogram (parasternal long-axis view) shows a large pseudoaneurysm (PsA) arising from the aorta and lined by intramural thrombus (arrowheads). The pseudoaneurysm compresses both ventricular cavities. The arrow points to the mitral ... Fig. 2 Computed tomogram of the chest (cross-sectional view) shows a large, narrow-necked pseudoaneurysm (arrow) arising from the ascending aorta and lined circumferentially by intramural thrombus. Fig. 3 Contrast-enhanced computed tomograms (3-dimensional reconstruction) show a large pseudoaneurysm of the ascending aorta in A) coronal and B) sagittal views. The patient underwent an emergency repeat sternotomy for the purpose of vascular graft repair. Perioperative coagulopathy resulted in severe, uncontrollable bleeding and in her death.

Collaboration


Dive into the Ashim Aggarwal's collaboration.

Top Co-Authors

Avatar

Geetha Bhat

University of Louisville

View shared research outputs
Top Co-Authors

Avatar

Antone Tatooles

Advocate Lutheran General Hospital

View shared research outputs
Top Co-Authors

Avatar

Pat Pappas

University of Louisville

View shared research outputs
Top Co-Authors

Avatar

Abrar Shah

University of Rochester

View shared research outputs
Top Co-Authors

Avatar

Anup Kumar

Michigan Technological University

View shared research outputs
Top Co-Authors

Avatar

Joseph Pyle

Rush University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Saadia Sherazi

University of Rochester Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Naila Choudhary

University of Rochester Medical Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge